Reaction of anhydrous zinc chloride with 2,3-thiophenedicarbaldehyde bis(semicarbazone) (2,3BSTCH2) and bis(thiosemicarbazone) (2,3BTSTCH2): Crystal structure of {[C6H5N2S]+[ZnCl3(C6H4N2S)]−} complex
the formation of compound [C6H5N2S]+[ZnCl3(C6H4N2S)]−}, where C6H4N2S is thieno[2,3-d]pyridazine, via an elimination-cyclisation reaction of the semi-carbazone or the thiosemicarbazone moiety. Crystalstructures of thieno[2,3-d]pyridazine and [C6H5N2S]+[ZnCl3(C6H4N2S)]−} are described.
无水氯化锌与2,3-噻吩二甲醛双(半碳zone)或2,3-双(硫半碳carb)的反应导致形成化合物[C 6 H 5 N 2 S] + [ZnCl 3(C 6 H 4 N 2 S)] - },其中C 6 H 4 N 2 S是噻吩并[2,3- d ]哒嗪,通过半卡巴zone或硫代半卡巴moiety部分的消除环化反应。噻吩并[2,3- d ]哒嗪和[C 6 H 5 N 2 S] +的晶体结构描述[ZnCl 3(C 6 H 4 N 2 S)] - }。
SMALL MOLECULE INHIBITORS OF NADS, NAMNAT, AND NMNAT
申请人:Brouillette Wayne J.
公开号:US20110275635A1
公开(公告)日:2011-11-10
Small molecule inhibitors of bacterial nicotinamide adenine dinucleotide synthetase (NADs), bacterial nicotinic acid mononucleotide adenylyltransferase (NaMNAT), and human nicotinamide mononucleotide adenylyltransferase (NMNAT) are provided, as well as methods of making and using the inhibitors.